2 arthritis drugs show different results in Covid-19 trials
By IANS | Updated: April 28, 2020 22:25 IST2020-04-28T22:13:27+5:302020-04-28T22:25:18+5:30
With different approaches to treating Covid-19 patients being tried, varying results of two different arthritis drug trials on patients have further complicated the search for a cure.
2 arthritis drugs show different results in Covid-19 trials
inhibitor tocilizumab rapidly reduced fever and improved oxygenation in severe patients, allowing for successful hospital discharge.
gb/arm
( With inputs from IANS )
Open in app